In HNSCC, mutations or amplifications of the genes encoding PI3K or AKT2 have been identified[47-49], but although a reduced protein expression of PTEN has been reported[27,50-52], rather low rates of mutations (8%) within the PTEN gene were found[53]. This evidence concerns the gene AKT2 and head and neck squamous cell carcinoma.